{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:07:28Z","timestamp":1793639248054,"version":"4.5.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41379-018-0164-x","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T03:39:20Z","timestamp":1541475560000},"page":"462-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["A pattern-based approach to the interpretation of skeletal muscle biopsies"],"prefix":"10.1016","volume":"32","author":[{"given":"Chunyu","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3815-2240","authenticated-orcid":false,"given":"Douglas C.","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9506-4709","authenticated-orcid":false,"given":"Peter","family":"Pytel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-018-0164-x_bib1","doi-asserted-by":"crossref","unstructured":"Domingo-Horne RM, Salajegheh MK. An approach to myopathy for the primary care clinician. Am J Med. 2017;131:237\u201343.","DOI":"10.1016\/j.amjmed.2017.10.016"},{"key":"10.1038\/s41379-018-0164-x_bib2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jpedsurg.2014.02.079","article-title":"Safety and yield of muscle biopsy in pediatric patients in the modern era","volume":"49","author":"Gibreel","year":"2014","journal-title":"J Pediatr Surg"},{"key":"10.1038\/s41379-018-0164-x_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/mus.23697","article-title":"Role of repeat skeletal muscle biopsy: how useful is it?","volume":"47","author":"Goutman","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1038\/s41379-018-0164-x_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1468-1331.2009.02765.x","article-title":"Open muscle biopsy in suspected myopathy: diagnostic yield and clinical utility","volume":"17","author":"Lai","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/03009742.2015.1086431","article-title":"The use of muscle biopsy in the diagnosis of systemic vasculitis affecting small to medium-sized vessels: a prospective evaluation in Japan","volume":"45","author":"Nunokawa","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1038\/s41379-018-0164-x_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mus.24447","article-title":"Diagnostic outcome of muscle biopsy","volume":"51","author":"Shaibani","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1038\/s41379-018-0164-x_bib7","first-page":"13","article-title":"Diagnostic utility of auto-antibodies in inflammatory muscle","volume":"2","author":"Allenbach","year":"2015","journal-title":"Dis J Neuromuscul Dis"},{"key":"10.1038\/s41379-018-0164-x_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1038\/s41379-018-0164-x_bib9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","article-title":"Advances in serological diagnostics of inflammatory myopathies","volume":"29","author":"Benveniste","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-018-0164-x_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-018-0164-x_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1038\/s41379-018-0164-x_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine"},{"key":"10.1038\/s41379-018-0164-x_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/s41379-018-0164-x_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MD.0000000000000222","article-title":"Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features","volume":"93","author":"Troyanov","year":"2014","journal-title":"Medicine"},{"key":"10.1038\/s41379-018-0164-x_bib16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"key":"10.1038\/s41379-018-0164-x_bib17","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"2017","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/s41379-018-0164-x_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","article-title":"205th ENMC International Workshop: pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands","volume":"25","author":"De Bleecker","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/s41379-018-0164-x_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.autrev.2017.05.003","article-title":"Integrated diagnosis project for inflammatory myopathies: an association between autoantibodies and muscle pathology","volume":"16","author":"Suzuki","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1038\/s41379-018-0164-x_bib20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1038\/s41379-018-0164-x_bib21","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/brain\/awv192","article-title":"Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis","volume":"138","author":"Mescam-Mancini","year":"2015","journal-title":"Brain"},{"key":"10.1038\/s41379-018-0164-x_bib22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0000000000001422","article-title":"Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy","volume":"84","author":"Stenzel","year":"2015","journal-title":"Neurology"},{"key":"10.1038\/s41379-018-0164-x_bib23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10067-014-2730-z","article-title":"Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis","volume":"33","author":"Aguila","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1038\/s41379-018-0164-x_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13075-015-0573-x","article-title":"Anti-PM\/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma","volume":"17","author":"Muro","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/s41379-018-0164-x_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180308","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"Pt 1","key":"10.1038\/s41379-018-0164-x_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/brain\/120.1.39","article-title":"Polymyositis with cytochrome oxidase negative muscle fibres: early quadriceps weakness and poor response to immunosuppressive therapy","volume":"120","author":"Blume","year":"1997","journal-title":"Brain"},{"key":"10.1038\/s41379-018-0164-x_bib27","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1724::AID-MUS15>3.0.CO;2-2","article-title":"Inflammatory myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment","volume":"21","author":"Levine","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1038\/s41379-018-0164-x_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.410370107","article-title":"Ragged red fibers in normal aging and inflammatory myopathy","volume":"37","author":"Rifai","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410390615","article-title":"Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients","volume":"39","author":"Santorelli","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib30","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-018-0164-x_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2051-5960-1-29","article-title":"Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies","volume":"1","author":"Hiniker","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.1038\/s41379-018-0164-x_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nmd.2016.02.014","article-title":"C5b-9 deposits on endomysial capillaries in non-dermatomyositis cases","volume":"26","author":"Braczynski","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/s41379-018-0164-x_bib33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","article-title":"Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM","volume":"70","author":"Chahin","year":"2008","journal-title":"Neurology"},{"key":"10.1038\/s41379-018-0164-x_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00401-009-0564-6","article-title":"p62\/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis","volume":"118","author":"Nogalska","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1038\/s41379-018-0164-x_bib35","first-page":"103","article-title":"Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis","volume":"30","author":"Dubourg","year":"2011","journal-title":"Acta Myol"},{"key":"10.1038\/s41379-018-0164-x_bib36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbadis.2014.08.007","article-title":"Hereditary inclusion-body myopathies","volume":"1852","author":"Broccolini","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/s41379-018-0164-x_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.0b013e318207b043","article-title":"Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients","volume":"76","author":"Durmus","year":"2011","journal-title":"Neurology"},{"key":"10.1038\/s41379-018-0164-x_bib38","doi-asserted-by":"crossref","first-page":"e52002","DOI":"10.1371\/journal.pone.0052002","article-title":"Rimmed vacuoles in Becker muscular dystrophy have similar features with inclusion myopathies","volume":"7","author":"Momma","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1038\/s41379-018-0164-x_bib39","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00415-010-5471-1","article-title":"Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy","volume":"257","author":"Reilich","year":"2010","journal-title":"J Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib40","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0046-8177(98)90425-7","article-title":"Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis","volume":"29","author":"Semino-Mora","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-018-0164-x_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mus.20683","article-title":"Granulomatous myositis: a clinical study of thirteen cases","volume":"35","author":"Le Roux","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1038\/s41379-018-0164-x_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s004150050236","article-title":"Clinical correlates of granulomas in muscle","volume":"245","author":"Mozaffar","year":"1998","journal-title":"J Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0046-8177(82)80298-0","article-title":"Pathologic features of muscle in systemic lupus erythematosus: a biopsy series with comparative clinical and immunopathologic observations","volume":"13","author":"Oxenhandler","year":"1982","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-018-0164-x_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/BOR.0000000000000336","article-title":"Myopathy in scleroderma and in other connective tissue diseases","volume":"28","author":"Paik","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1038\/s41379-018-0164-x_bib45","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/acr.23177","article-title":"Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: a systematic review of the literature","volume":"69","author":"Cappelli","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1038\/s41379-018-0164-x_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5692\/clinicalneurol.cn-000991","article-title":"A case of myasthenia gravis and myositis induced by nivolumab","volume":"57","author":"Konoeda","year":"2017","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1038\/s41379-018-0164-x_bib47","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/PAS.0b013e31819e63fe","article-title":"Focal myositis: a clinicopathologic study of 115 cases of an intramuscular mass-like reactive process","volume":"33","author":"Auerbach","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0164-x_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/CND.0000000000000115","article-title":"Chronic myopathy associated with anti-signal recognition particle antibodies can be misdiagnosed as facioscapulohumeral muscular dystrophy","volume":"17","author":"Ikeda","year":"2016","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1038\/s41379-018-0164-x_bib49","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/mus.25567","article-title":"Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child","volume":"56","author":"Mohassel","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1038\/s41379-018-0164-x_bib50","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41379-018-0164-x_bib51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41379-018-0164-x_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ncl.2014.04.009","article-title":"Toxic myopathies","volume":"32","author":"Pasnoor","year":"2014","journal-title":"Neurol Clin"},{"key":"10.1038\/s41379-018-0164-x_bib53","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/01.CON.0000440663.26427.f4","article-title":"Toxic myopathies","volume":"19","author":"Mammen","year":"2013","journal-title":"Continuum"},{"key":"10.1038\/s41379-018-0164-x_bib54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.bor.0000434673.85515.89","article-title":"The spectrum of statin myopathy","volume":"25","author":"Mohassel","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1038\/s41379-018-0164-x_bib55","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","article-title":"Mitochondrial myopathy caused by long-term zidovudine therapy","volume":"322","author":"Dalakas","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-018-0164-x_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-510X(95)00005-M","article-title":"Significance of type II fiber atrophy in chronic alcoholic myopathy","volume":"130","author":"Fernandez-Sola","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1038\/s41379-018-0164-x_bib57","first-page":"125","article-title":"Alcoholic muscle disease","volume":"20","author":"Martin","year":"1985","journal-title":"Alcohol Alcohol"},{"key":"10.1038\/s41379-018-0164-x_bib58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/practneurol-2017-001708","article-title":"Metabolic myopathies: a practical approach","volume":"18","author":"Lilleker","year":"2018","journal-title":"Pract Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","article-title":"Approach to the diagnosis of congenital myopathies","volume":"24","author":"North","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/s41379-018-0164-x_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/WNL.0000000000001110","article-title":"Congenital myopathies: Natural history of a large pediatric cohort","volume":"84","author":"Colombo","year":"2015","journal-title":"Neurology"},{"key":"10.1038\/s41379-018-0164-x_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.nmd.2013.12.011","article-title":"Diagnostic approach to the congenital muscular dystrophies","volume":"24","author":"Bonnemann","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/s41379-018-0164-x_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nmd.2010.12.007","article-title":"Myofibrillar myopathies","volume":"21","author":"Selcen","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/s41379-018-0164-x_bib63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol Clin"},{"key":"10.1038\/s41379-018-0164-x_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.gde.2017.03.007","article-title":"Myotonic dystrophy: approach to therapy","volume":"44","author":"Thornton","year":"2017","journal-title":"Curr Opin Genet Dev"},{"key":"10.1038\/s41379-018-0164-x_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gde.2015.08.007","article-title":"Genetic and epigenetic contributors to FSHD","volume":"33","author":"Daxinger","year":"2015","journal-title":"Curr Opin Genet Dev"},{"key":"10.1038\/s41379-018-0164-x_bib66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/nan.12385","article-title":"Myopathology in times of modern imaging","volume":"43","author":"Jungbluth","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1038\/s41379-018-0164-x_bib67","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s00415-016-8350-6","article-title":"Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review","volume":"264","author":"Leung","year":"2017","journal-title":"J Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib68","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0022-510X(95)00147-T","article-title":"Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype","volume":"132","author":"Morandi","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1038\/s41379-018-0164-x_bib69","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2990.2004.00561.x","article-title":"Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions","volume":"30","author":"Torelli","year":"2004","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1038\/s41379-018-0164-x_bib70","first-page":"122","article-title":"Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy","volume":"35","author":"Bello","year":"2016","journal-title":"Acta Myol"},{"key":"10.1038\/s41379-018-0164-x_bib71","first-page":"1","article-title":"Genetic basis of limb-girdle muscular dystrophies: the 2014 update","volume":"33","author":"Nigro","year":"2014","journal-title":"Acta Myol"},{"key":"10.1038\/s41379-018-0164-x_bib72","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.jnen.0000235854.77716.6c","article-title":"Limb-girdle muscular dystrophy in the United States","volume":"65","author":"Moore","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib73","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/humu.20642","article-title":"Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients","volume":"29","author":"Guglieri","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1038\/s41379-018-0164-x_bib74","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awp236","article-title":"Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population","volume":"132","author":"Norwood","year":"2009","journal-title":"Brain"},{"key":"10.1038\/s41379-018-0164-x_bib75","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1017\/cjn.2015.386","article-title":"Genetic myopathies initially diagnosed and treated as inflammatory myopathy","volume":"43","author":"Tarnopolsky","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1038\/s41379-018-0164-x_bib76","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/BOR.0000000000000441","article-title":"Which nonautoimmune myopathies are most frequently misdiagnosed as myositis?","volume":"29","author":"Mammen","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1038\/s41379-018-0164-x_bib77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.21309","article-title":"Dysferlin-deficient muscular dystrophy features amyloidosis","volume":"63","author":"Spuler","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib78","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","article-title":"Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction","volume":"14","author":"Jungbluth","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib79","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/WCO.0000000000000372","article-title":"Congenital myopathies: not only a paediatric topic","volume":"29","author":"Jungbluth","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib80","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.nmd.2009.02.005","article-title":"Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"19","author":"Jungbluth","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/s41379-018-0164-x_bib81","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/01.wnl.0000180362.90078.dc","article-title":"Sporadic late onset nemaline myopathy","volume":"65","author":"Chahin","year":"2005","journal-title":"Neurology"},{"key":"10.1038\/s41379-018-0164-x_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-017-0640-2","article-title":"Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases","volume":"12","author":"Schnitzler","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1038\/s41379-018-0164-x_bib83","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2013.08.005","article-title":"Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies","volume":"110","author":"Preisler","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1038\/s41379-018-0164-x_bib84","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pcl.2016.08.011","article-title":"Presentation and diagnostic evaluation of mitochondrial disease","volume":"64","author":"Dimmock","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"10.1038\/s41379-018-0164-x_bib85","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ana.410290606","article-title":"Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes","volume":"29","author":"Hasegawa","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib86","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1212\/01.WNL.0000033795.17156.00","article-title":"Diagnostic criteria for respiratory chain disorders in adults and children","volume":"59","author":"Bernier","year":"2002","journal-title":"Neurology"},{"key":"10.1038\/s41379-018-0164-x_bib87","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0960-8966(93)90120-9","article-title":"Morphological analyses of paraspinal muscles: comparison of progressive lumbar kyphosis (camptocormia) and narrowing of lumbar canal by disc protrusions","volume":"3","author":"Delisle","year":"1993","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/s41379-018-0164-x_bib88","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1532-5415.1977.tb00274.x","article-title":"Histochemical and ultrastructural changes in senile human skeletal muscle","volume":"25","author":"Tomonaga","year":"1977","journal-title":"J Am Geriatr Soc"},{"key":"10.1038\/s41379-018-0164-x_bib89","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet Med"},{"key":"10.1038\/s41379-018-0164-x_bib90","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1056\/NEJM198712173172511","article-title":"Progressive nemaline (rod) myopathy associated with HIV infection","volume":"317","author":"Dalakas","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-018-0164-x_bib91","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archneur.1981.00510120061010","article-title":"Adult-onset nemaline rods in a patient treated for suspected dermatomyositis. Study with two-dimensional electrophoresis","volume":"38","author":"Danon","year":"1981","journal-title":"Arch Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib92","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jocn.2007.11.010","article-title":"Tubular aggregate myopathy: a rare form of myopathy","volume":"15","author":"Jain","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1038\/s41379-018-0164-x_bib93","doi-asserted-by":"crossref","first-page":"E1952","DOI":"10.3390\/ijms17111952","article-title":"Calcium dyshomeostasis in tubular aggregate myopathy","volume":"17","author":"Lee","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1038\/s41379-018-0164-x_bib94","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/path.1832","article-title":"The origin of tubular aggregates in human myopathies","volume":"207","author":"Chevessier","year":"2005","journal-title":"J Pathol"},{"key":"10.1038\/s41379-018-0164-x_bib95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbadis.2014.06.031","article-title":"Spectrum of metabolic myopathies","volume":"1852","author":"Angelini","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/s41379-018-0164-x_bib96","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10545-014-9728-1","article-title":"Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study","volume":"37","author":"Anderson","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/s41379-018-0164-x_bib97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11910-010-0154-y","article-title":"Lipid storage myopathy","volume":"11","author":"Liang","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1038\/s41379-018-0164-x_bib98","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnen\/64.6.513","article-title":"Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies","volume":"64","author":"Sugie","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/s41379-018-0164-x_bib99","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-1073-6","article-title":"VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathy","volume":"125","author":"Ramachandran","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1038\/s41379-018-0164-x_bib100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1212\/WNL.59.4.596","article-title":"Narrowing in on the causative defect of an intriguing X-linked myopathy with excessive autophagy","volume":"59","author":"Minassian","year":"2002","journal-title":"Neurology"},{"key":"10.1038\/s41379-018-0164-x_bib101","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0002-8703(05)80264-9","article-title":"Amiodarone toxicity: myopathy and neuropathy","volume":"119","author":"Fernando Roth","year":"1990","journal-title":"Am Heart J"},{"key":"10.1038\/s41379-018-0164-x_bib102","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ajpath.2015.11.010","article-title":"Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression","volume":"186","author":"Allenbach","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-018-0164-x_bib103","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","article-title":"Clinical and serologic characterization of an argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein","volume":"36","author":"Espada","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1038\/s41379-018-0164-x_bib104","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/annrheumdis-2014-206691","article-title":"Disease specificity of autoantibodies to cytosolic 5\u2018-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases","volume":"75","author":"Herbert","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/s41379-018-0164-x_bib105","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/s41379-018-0164-x_bib106","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1038\/s41379-018-0164-x_bib107","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","article-title":"Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease","volume":"91","author":"Rigolet","year":"2012","journal-title":"Medicine"},{"key":"10.1038\/s41379-018-0164-x_bib108","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-018-0164-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-018-0164-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-018-0164-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:49:03Z","timestamp":1760230143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222014569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":108,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0893395222014569"],"URL":"https:\/\/doi.org\/10.1038\/s41379-018-0164-x","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pattern-based approach to the interpretation of skeletal muscle biopsies","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-018-0164-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}